- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05383469
Efficacy of Active Versus Passive Methods in Chronic Venous Insufficiency
Comparison of the Efficacy of Active Versus Passive Methods in Patients With Chronic Venous Insufficiency
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Volunteers who have been diagnosed with venous insufficiency according to the criteria of inclusion, who applied to Cardiovascular Surgery Department will be included this study.
Participants will be randomly allocated 3 groups using the 'Research Randomizer' website. In all groups, a common evaluation protocol will be applied to the patients.
Compression therapy will be applied to the first group. Active treatment in addition to compression therapy will be applied to the second group. Passive treatment in addition to compression therapy will be applied to the third group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Saliha Gürdal Karakelle, MSc
- Phone Number: 00905555925304
- Email: salihagurdal@hotmail.com
Study Contact Backup
- Name: İpek Yeldan Karagöz, PhD
- Phone Number: 00905426513818
- Email: ipekyeldan@gmail.com
Study Locations
-
-
Büyükçekmece
-
Istanbul, Büyükçekmece, Turkey, 34500
- Istanbul University-Cerrahpasa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of venous insufficiency with duplex ultrasonography
- Classification of CEAP (Clinical-Etiological-Anatomical-Pathological) used in venous insufficiency is C3-C4-C5-C6
- Ankle-brachial index (ABI) is less than 0.7
- Possibility to communicate in written and verbal in Turkish
- Have a level of cognitive ability to understand the instructions given
Exclusion Criteria:
- Presence of deep vein thrombosis
- Ulceration or open burn wound in lower extremity greater than 4 cm
- Presence of infected ulceration
- Cardiorespiratory insufficiency
- Orthopedic, rheumatologic or neurological comorbidities restrain the exercise in the lower extremity
- Presence of a psychiatric illness requiring the use of prescribed medicines
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Compression Group
Routine compression therapy will be administered.
|
Compression therapy is a treatment applied to patients in the form of Four Layer Compression Bandage and Compression Stocking.
Four Layer Compression Bandage is a treatment that requires four different types of bandages.
The compression stocking is an elastic stock with various tension and length.
|
Experimental: Active Group
Exercise training will be administered.
|
Compression therapy is a treatment applied to patients in the form of Four Layer Compression Bandage and Compression Stocking.
Four Layer Compression Bandage is a treatment that requires four different types of bandages.
The compression stocking is an elastic stock with various tension and length.
Endurance training with a resistance-free bicycle ergometer Strength training with bodyweight Non-resistance ankle pumping exercises
|
Experimental: Passive Group
Massageand neuromuscular electrical stimulation will be administered.
|
Compression therapy is a treatment applied to patients in the form of Four Layer Compression Bandage and Compression Stocking.
Four Layer Compression Bandage is a treatment that requires four different types of bandages.
The compression stocking is an elastic stock with various tension and length.
Classical massage including superficial and deep stroking and friction methods for the lower extremity.
Symmetrical biphasic current at a frequency of 30-85 Hz
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Circumference measurements
Time Frame: Change from Baseline circumferences at 8 weeks.
|
Circumference measurements will be recorded at 4 cm intervals to evaluated to edema.
|
Change from Baseline circumferences at 8 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale (VAS)
Time Frame: Assessment will be performed at baseline and at 8 weeks.
|
The levels of pain felt rest/activity/night will be measured using visual analogue scale (VAS).
Patients will be asked to evaluate their pain status with a 10-point scale and high scores are positively correlated with pain.
|
Assessment will be performed at baseline and at 8 weeks.
|
Venous Clinical Severity Score (VCSS)
Time Frame: Assessment will be performed tat baseline and at 8 weeks.
|
Clinical severity will be measured by Venous Clinical Severity Score (VCSS).The VCSS was subsequently developed as an evaluative instrument that would be responsive to changes in disease severity over time and in response to treatment.The total score is at least 0 and at most 30, and the low scores are positively correlated with the severe clinical condition.
|
Assessment will be performed tat baseline and at 8 weeks.
|
Handheld Dynamometer
Time Frame: Assessment will be performed at baseline and at 8 weeks.
|
The muscle strength of the gastrocnemius and tibialis anterior muscles will be evaluated using the handheld dynamometer.
|
Assessment will be performed at baseline and at 8 weeks.
|
6-Minute Walking Test
Time Frame: Assessment will be performed at baseline and at 8 weeks.
|
Functional capacity will be evaluated with the 6-minute walking test.
The 6-minute walking test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes.
|
Assessment will be performed at baseline and at 8 weeks.
|
10-Meter Walking Test
Time Frame: Assessment will be performed at baseline and at 8 weeks.
|
Walking speed will be evaluated with the 10-meter walking test.
10-meter walking test is used to assess walking speed in meters/second (m/s) over a short distance.
|
Assessment will be performed at baseline and at 8 weeks.
|
Chronic Venous Disease Quality of Life Questionnaire (CIVIQ) 20
Time Frame: Assessment will be performed at baseline and at 8 weeks.
|
Quality of Life will be evaluated with the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ) 20.
CIVIQ 20 is a disease-related quality of life assessment form especially for chronic venous insufficiency patients.
The total score is at least 0 and at most 100, and the higher scores indicate better quality of life.
|
Assessment will be performed at baseline and at 8 weeks.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 99984023-302.14.68-
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Venous Insufficiency
-
Value Outcomes Ltd.Alfasigma S.p.A.RecruitingChronic Venous Disease | Chronic Insufficiency VenousCzechia
-
CEN BiotechTOWN HALL OF ROYATActive, not recruiting
-
State Budgetary Healthcare Institution, National...CompletedEndothelial Dysfunction | Venous Insufficiency of Leg | Venous Insufficiency (Chronic)(Peripheral)Russian Federation
-
TheraclionRecruitingChronic Venous InsufficiencyUnited States, Austria, Czechia
-
Technical University of LisbonFundação para a Ciência e a Tecnologia; Escola Superior de Saúde Dr. Lopes...CompletedChronic Venous InsufficiencyPortugal
-
Angiodynamics, Inc.Completed
-
Shannon HernonGalway ClinicUnknownChronic Venous InsufficiencyIreland
-
Virginia Commonwealth UniversityCompletedChronic Venous InsufficiencyUnited States
-
University of ZurichUnknown
-
InnoVeinRecruitingChronic Venous InsufficiencyAustralia
Clinical Trials on Compression Therapy
-
Venous Health Systems, Inc.CompletedVenous ThrombosisUnited States
-
Belarusian State Medical UniversityRecruitingQuality of Life | Pregnancy Related | Varicose VeinsBelarus
-
University of OklahomaTerminated
-
University Hospital ErlangenCompletedDiabetes Mellitus | Peripheral Arterial Disease | Leg EdemaGermany
-
MiMedx Group, Inc.CompletedVenous Leg UlcerUnited States
-
Acibadem UniversityRecruitingBreast Cancer and RehabilitationTurkey
-
Józef Piłsudski University of Physical EducationUniversity School of Physical Education in WroclawRecruitingMuscle Pain | Migraine | Cervical Pain | Trigger Point Pain, Myofascial | Pain, Shoulder | Trapezius Muscle Strain Left | Trapezius Muscle Strain RightPoland
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Western Vascular Institute, IrelandCompleted
-
Sykehuset TelemarkUniversity of Oslo; Ohio State UniversityRecruitingBreast Cancer | Secondary LymphedemaNorway